Evidence map›Paper›PMID 41959632›Full record

ArticleFrontiers in neurology

Risk factors and nomogram for cognitive impairment after stereotactic drainage of spontaneous intracerebral hemorrhage.

Min Gong, Xiaohong Fu, Yuanjun Xin, Hang Li, Shaofu Zhang

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min GongDepartment of Cerebrovascular Diseases, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Xiaohong FuDepartment of Cerebrovascular Diseases, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yuanjun XinDepartment of Cerebrovascular Diseases, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Hang LiDepartment of Cerebrovascular Diseases, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Shaofu ZhangDepartment of Cerebrovascular Diseases, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the risk factors for cognitive impairment after stereotactic puncture and drainage for spontaneous intracerebral hemorrhage (SICH) and to establish a nomogram prediction model. Methods: A retrospective analysis was conducted on 143 patients who underwent stereotactic puncture and drainage for SICH between June 2022 and June 2024. Patients were divided into cognitive impairment group ( Results: The incidence of cognitive impairment at 3 months was 39.86% (57/143). Multivariate logistic regression identified five independent risk factors: age (OR = 1.145, 95% CI: 1.089-1.205, Conclusion: Advanced age, lower preoperative GCS score, larger hematoma volume, basal ganglia hemorrhage, and elevated postoperative intracranial pressure are independent risk factors for cognitive impairment at 3 months following stereotactic drainage for SICH. The nomogram may assist in early identification of high-risk patients, though external validation is warranted.

Indexed as

cognitive impairmentnomogrampost-stroke cognitive impairmentrisk factorsspontaneous intracerebral hemorrhagestereotactic puncture and drainage

Identifiers

PMID41959632
PMCPMC13056658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.